Raporty Spółek ESPI/EBI

January to September 2026 unaudited interim report of the Krka Group and Krka KRKA. TOVARNA ZDRAVIL. D.D.. NOVO MESTO (SI0031102120)

12-11-2026 08:15:47 | ESPI | 47/2026
oUNI-EN: January to September 2026 unaudited interim report of the Krka Group and Krka

PAP
Data: 2026-11-12

Firma: KRKA, TOVARNA ZDRAVIL D.D.

oSpis tresci:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

oSpis zalacznikow:
Znaleziono 2 załączniki
  • January to September 2026 unaudited interim report of the Krka group and Krka.pdf
  • Arkusz: REPORT
  • Press Release.pdf
  • Arkusz: REPORT

    Nazwa arkusza: REPORT


    POLISH FINANCIAL SUPERVISION AUTHORITY
    UNI - EN REPORT No 47 / 2026
    Date of issue: 2026-11-12
    Short name of the issuer
    KRKA
    Subject
    January to September 2026 unaudited interim report of the Krka Group and Krka
    Official market - legal basis
    Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe
    Unofficial market - legal basis
    Contents of the report:
    Based on Article 26 of the Rules of the Ljubljana Stock Exchange, the company Krka, d. d., Novo mesto publishes the January to September 2026 unaudited interim report of the Krka Group and Krka.

    The report and press release are attached.


    The report will be published on the Company's website _www.krka.biz_ from 12 November 2026 onwards, for a minimum period of 5 years.
    Annexes
    File Description
    January to September 2026 unaudited interim report of the Krka group and Krka.pdf January to September 2026 unaudited interim report of the Krka Group and Krka
    Press Release.pdf Press Release

    Nazwa arkusza: ESAP METADATE


    Legal framework Type of information
    TRANSD Inside information
    RegulatoryData
    Collection Body PLKNF
    Unique data record identifier
    Type of submission New _to be used for new information_
    Voluntary information flag
    Date or period covered [Date or beginning of the period to which the information relates] 2026-01-01
    Date or period covered [Date or end of the period to which the information relates] 2026-09-30
    Personal data flag
    Macierzyste państwo członkowskie, w stosownych przypadkach PL
    DocumentReference
    Język, w którym przekazano informacje Oryginał _ORIG_ czy tłumaczenie _TRAN_ Numer referencyjny pliku danych
    PL ORIG
    SubmittingEntity
    Submitting entity LEI or Submitting entity name - natural person
    RelatedEntity/LegalPerson
    Entity LEI Size of the entity Industry sector_s_
    549300H9RLRTRTLRUZ73 Large group _acc. NACE_: C

    Nazwa arkusza: INFORMATION ABOUT THE ENTITY


    KRKA, TOVARNA ZDRAVIL D.D.
    _fullname of the issuer_
    KRKA Farmaceutyczny _far_
    _short name of the issuer_ _sector according to clasification
    of the WSE in Warsow_
    8501 Nove Mesto
    _post code_ _city_
    Smarjeska 6
    _street_ _number_
    +386 7 331 21 11 +386 7 332 15 37
    _phone number_ _fax_
    _e-mail_ _web site_
    nie dotyczy
    _NIP_ _REGON_

    Nazwa arkusza: SIGNATURE OF PERSONS REPRESENTING THE COMPANY


    SIGNATURE OF PERSONS REPRESENTING THE COMPANY
    Date Name Position / Function Signature
    2026-11-12 Jože Colarič President of the Management Board and CEO


    Identyfikator raportu jjvuszwyf1
    Nazwa raportu UNI-EN
    Symbol raportu UNI-EN
    Nazwa emitenta KRKA, TOVARNA ZDRAVIL D.D.
    Symbol Emitenta KRKA
    Tytul January to September 2026 unaudited interim report of the Krka Group and Krka
    Sektor Farmaceutyczny (far)
    Kod 8501
    Miasto Nove Mesto
    Ulica Smarjeska
    Nr 6
    Tel. +386 7 331 21 11
    Fax +386 7 332 15 37
    e-mail
    NIP nie dotyczy
    REGON
    Data sporzadzenia 2026-11-12
    Rok biezacy 2026
    Numer 47
    adres www
    Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2026 Copyright PAP SA - Wszelkie prawa zastrzezone.